Optimal first‐line treatment for advanced thymic carcinoma-Reference-Cited by-同舟云学术

Optimal first‐line treatment for advanced thymic carcinoma

Published:2019-10 Issue:11 Volume:10 Page:2081-2087
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Yang Xue¹^ORCID,Zhuo Minglei¹^ORCID,Shi Anhui²,Yang Shengnan³,Wang Ziping¹^ORCID,Wu Meina¹,An Tongtong¹,Wang Yuyan¹,Li Jianjie¹,Zhong Jia¹^ORCID,Chen Hanxiao¹,Jia Bo¹,Dong Zhi¹,Zhao Jun¹

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical OncologyPeking University Cancer Hospital and Institute Beijing China

2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiation OncologyPeking University Cancer Hospital and Institute Beijing China

3. Department of Geriatric MedicineThe First Affiliated Hospital of Zhengzhou University Zhengzhou China

Funder

National Basic Research Program of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13181

Reference25 articles.

1. Proceedings of the First International Conference on Thymic Malignancies. August 20‐21, 2009. Bethesda, Maryland, USA;J Thorac Oncol,2010

2. Management of Stage I and II Thymoma